Clinicopathological and prognostic significance of p16 protein in nasopharynx cancer patients: A PRISMA-compliant meta-analysis

BACKGROUND: p16 protein is significantly down-regulated in several cancers, which reveals that it may be a potential biomarker for cancers. However, the clinicopathological and prognostic value of p16 protein in nasopharynx cancer patients remains unclear. Therefore, we performed a meta-analysis to...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Lingling, Song, Jingjing, Huang, Qingli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426621/
https://www.ncbi.nlm.nih.gov/pubmed/30882625
http://dx.doi.org/10.1097/MD.0000000000014602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426621/
https://www.ncbi.nlm.nih.gov/pubmed/30882625
http://dx.doi.org/10.1097/MD.0000000000014602

Ejemplares similares